A murine model of Madurella mycetomatis eumycetoma

被引:28
作者
Ahmed, AO
van Vianen, W
ten Kate, MT
van de Sande, WWJ
van Belkum, A
Fahal, AH
Verbrugh, HA
Bakker-Woudenberg, IAJM
机构
[1] Univ Med Ctr Rotterdam, Erasmus MC, Dept Med Microbiol & Infect Dis, NL-3015 GD Rotterdam, Netherlands
[2] Univ Khartoum, Inst Endem Dis, Mycetoma Res Grp, Khartoum, Sudan
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2003年 / 37卷 / 01期
关键词
mycetoma; Madurella mycetomatis; mouse infection model;
D O I
10.1016/S0928-8244(03)00096-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Eumycetoma due to Madurella mycetomatis is a major mycological health problem in endemic areas. We infected BALB/c mice (male or female) with various amounts of M. mycetomatis mycelium, containing sterilized soil as a natural adjuvant or Freund's incomplete adjuvant. Mice differed with respect to age and immune status. Intraperitoneal, subcutaneous and intravenous inoculation was explored and survival was monitored. Mice were killed at various intervals after inoculation, checked for the presence of the characteristic black grains, and organs were cultured for M. mycetomatis. Infected organs were subjected to histopathological examination. Immunocompetent male mice were as susceptible as immunocompromised female mice, but showed higher mortality rates. In conclusion, a reproducible mouse model of intraperitoneal M. mycetomatis infection with characteristic black grains in immunocompetent adult or young female mice was developed. Although this experimental model does not simulate macroscopic features of the subcutaneous M. mycetomatis infection in humans, the histopathological characteristics of the lesions and the development of black grains are clearly representative for the human infection. This model will enable further studies on the pathogenesis as well as prevention and treatment of the fungal infection. (C) 2003 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 24 条
  • [1] ABBOTT P., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P11, DOI 10.1016/0035-9203(56)90004-9
  • [2] Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan
    Ahmed, A
    Adelmann, D
    Fahal, A
    Verbrugh, H
    van Belkum, A
    de Hoog, S
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) : 1031 - 1036
  • [3] Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis
    Ahmed, AOA
    Mukhtar, MM
    Kools-Sijmons, M
    Fahal, AH
    de Hoog, S
    Van den Ende, BG
    Zijlstra, EE
    Verbrugh, H
    Abugroun, ESAM
    Elhassan, AM
    van Belkum, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (10) : 3175 - 3178
  • [4] Unexpected high prevalence of secondary bacterial infection in patients with mycetoma
    Ahmed, AOA
    Abugroun, ESAM
    Fahal, AH
    Zijlstra, EE
    van Belkum, A
    Verbrugh, HA
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (03) : 850 - 851
  • [5] NOTE ON THE ISOLATION OF PATHOGENIC AEROBIC ACTINOMYCETES FROM SUDANESE SOILS
    AJELLO, G
    BROWN, J
    MAHGOUB, ES
    AJELLO, L
    [J]. CURRENT MICROBIOLOGY, 1979, 2 (01) : 25 - 26
  • [6] Boiron P, 1998, MED MYCOL, V36, P26
  • [7] BORELLI D., 1957, Bol. Lab. clin. (Caracas)., V2, P1
  • [8] CAVANAGH LL, 1974, SABOURAUDIA, V12, P258
  • [9] CREMER G, 1995, MED MICROBIOL LETT, V4, P76
  • [10] El Hassan AM, 2001, T ROY SOC TROP MED H, V95, P89, DOI 10.1016/S0035-9203(01)90346-3